Navigation Links
Bryan Coddington and David Blewitt to Present at ServiceMax Maximize 2017 in Las Vegas
Date:9/18/2017

USDM Life Sciences, the leading risk management, technological innovation and business process optimization firm for the life sciences and healthcare industries, announces Bryan Coddington and David Blewitt’s presentation at the ServiceMax Maximize 2017 conference.

What: Digital Transformation in Medical Device – The Journey to FDA Compliant Field Service and Beyond!
Who: Bryan Coddington, VP of Cloud Technology, and David Blewitt, VP of Cloud Compliance at USDM
Where: Medical Device Manufacturing Session at ServiceMax Maximize 2017, Encore at Wynn Hotel, Las Vegas, Nevada
When: Monday, September 18th, 1:45-2:30pm

The presentation, “Digital Transformation in Medical Device – The Journey to FDA Compliant Field Service and Beyond,” will discuss proven strategies for qualifying and validating a cloud system and offer thoughts on how to digitally transform field service businesses by integrating cloud processes and applications such as eSignature, QMS, Document Management, Training, and more.

“David and I are excited to present at Maximize where we’ll be showing how today’s companies are exceeding their goals and reinventing their businesses through digital transformation,” said Bryan Coddington. “This often means throwing out the book and finding solutions that are new, bold, and even disruptive to the organization. As a medical device company, those solutions aren’t just about the latest and greatest technology, but ones that also meet the rigor and requirements of the FDA.”

Bryan has over 20 years of experience in Information Technology with the last 10 focused solely helping companies maximize their investment in cloud-based applications. He has implemented over 100 cloud projects across the globe, including those in the medical device, pharmaceutical, and biotechnology industries. His key skills include cloud system architecture, system integration, cloud application validation, business process, and leading successful deployments that deliver solid ROI for customers.

David is an accomplished Life Sciences Regulatory and IS Compliance Professional with extensive hands-on and leadership experience in the Pharmaceutical, Medical Device, Biotech and Blood Management Industries, specifically in the fields of; Computer Systems Validation, Risk Management, Issue Investigation – Root Cause Analysis and Remediation, Quality Assurance, Software Development Lifecycle, Lean IS Compliance Enhancement Initiatives, Business Analysis, Product Lifecycle Management and Systems/Process analysis with Compliance Roadmap development.

USDM helps Life Sciences companies move applications and business processes to the Cloud. Our team of experts understand compliance, validation, implementation, mobile, data security, data migration, and system integration, and we ensure that leading cloud vendors meet and maintain compliance regulations around the globe.

ServiceMax Maximize is September 18–20, 2017 at the Encore at Wynn Hotel in Las Vegas, Nevada.

About USDM Life Sciences:
USDM Life Sciences is a global life science and healthcare services company, providing strategy and compliant technology solutions to regulated industries. If you work in Life Sciences or Healthcare, partnering with USDM Life Sciences makes it easy to accelerate innovation and maximize productivity. USDM Life Sciences only focuses on regulated industries and has built trusted partnerships with the most innovative technology companies in the world, and boast a staff of industry leading experts in the areas of technology and compliance. USDM Life Sciences is doing business as USDM Europe GmbH in Germany.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14704209.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Bryan, Garnier & Co Announces the Successful $275m IPO for Galapagos NV, the Largest Nasdaq IPO of European Biotech
2. USDM Life Sciences Names Bryan Coddington VP of Cloud Technology for Regulated Life Sciences
3. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
4. Thirty-Year Marketing Veteran, David L. Politis, Joins ExcitePCR as its Chief Marketing & Sales Officer
5. Impossible Foods hires genomics pioneer and informatics expert David Lipman as Chief Science Officer
6. Rhythm Appoints Head of Sanofi Genzyme, Dr. David Meeker, as Chairman of Board of Directors
7. Life Legal Defense Foundation Seeking Nationwide Support for David Daleiden Legal Battle in California
8. Former Allergan Chief David Pyott Signs on as Special Advisor to Sienna Biopharmaceuticals
9. Animated Dynamics, Inc. Co-Founder, Dr. David Nolte, Receives Award From Purdue University For Commercial Patent
10. Dr. David Samadi Explains Why Enlargement Of The Prostate Is More Likely In Obese Men
11. Study Suggests Improved Method For Pinpointing If Prostate Cancer Will Return - Dr. David Samadi Investigates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):